منابع مشابه
Hidden overhead costs: is Canada's system really less expensive?
Prologue: Canada’s provincial health insurance scheme is a source of endless fascination to policymakers advocating health system reform. Whether one is an advocate or a or a detractor of Canada’s plan us a model for the United States, an important issue that engages the antagonists is how much it costs to operate compared with America’s pluralistic and mostly private health insurance approach....
متن کاملEarly screening of gestational diabetes mellitus using maternal hemoglobin A1C: Revision of current screening guidelines
Background: HbA1C has been a known predictor and diagnostic test for diabetes type 2. However, this test has not yet been widely studied in GDM and more importantly no cutoff point has been defined for HbA1C in GDM. We investigated the efficacy of screening during first and second trimester of pregnancy and defined appropriate cutoff points according to HbA1C and FBS for predicting maternal GDM...
متن کاملHow low do we fall to lower hemoglobin A1c? SGLT2 inhibitors: Effective drugs or expensive toxins!
SGLT2 inhibitors improve hyperglycemia with a decline in body weight and blood pressure, the outcomes touted to be of major importance in management of type 2 diabetes. However, the efficacy in lowering glycemia is very modest and imparts an undue cost burden on patients. Moreover, the declines in body weight and blood pressure are slight at best and orthostatic hypotension and its manifestatio...
متن کاملGlycohemoglobin A1c: A promising screening tool in gestational diabetes mellitus
CONTEXT Current screening tests for gestational diabetes mellitus (GDM) are inconvenient. Therefore, alternative screening tests for GDM are desirable. The use of glycohemoglobin A1c (HbA1c) in screening for GDM remains controversial. AIM We undertook this study to evaluate the utility of HbA1c in screening for GDM. SETTINGS AND DESIGN Retrospective study in a tertiary teaching hospital. ...
متن کاملCervical cancer screening: Less testing, smarter testing.
In its 2009 recommendations for cervical cancer screening, the American College of Obstetricians and Gynecologists (ACOG) calls for less-frequent but smarter screening that integrates testing for human papillomavirus (HPV) infection with the Papanicolaou (Pap) test. We review the recommendations from this and other organizations and how and why they are evolving.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Medical Association Journal
سال: 2013
ISSN: 0820-3946,1488-2329
DOI: 10.1503/cmaj.113-2120